Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Sagimet Biosciences Inc.

    NASDAQ: SGMT · Real-Time Price · USD
    8.27
    -0.34 (-3.95%)
    At close: Jun 13, 2025, 3:59 PM
    8.40
    1.57%
    After-hours: Jun 13, 2025, 05:50 PM EDT

    Sagimet Biosciences Statistics

    Share Statistics

    Sagimet Biosciences has 30.67M shares outstanding. The number of shares has increased by -3.88% in one year.

    Shares Outstanding

    n/a
    		 30.67M

    Shares Change (YoY)

    n/a
    		 -3.88%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 55.55%

    Shares Floating

    n/a
    		 23.62M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,149

    FTD / Avg. Volume

    n/a
    		 0.1%

    Short Selling Information

    The latest short interest is 3.66M, so 11.37% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 3.66M

    Short % of Shares Out

    n/a
    		 11.37%

    Short % of Float

    n/a
    		 12.89%

    Short Ratio (days to cover)

    n/a
    		 10.14

    Valuation Ratios

    The PE ratio is -3.1 and the forward PE ratio is -2.82. Sagimet Biosciences's PEG ratio is 0.07.

    PE Ratio

    n/a
    		 -3.1

    Forward PE

    n/a
    		 -2.82

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 1.8

    PB Ratio

    n/a
    		 0.91

    P/FCF Ratio

    n/a
    		 -3.32

    PEG Ratio

    n/a
    		 0.07
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Sagimet Biosciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 34.3, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 34.3

    Quick Ratio

    n/a
    		 34.3

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-3,254,785.71

    Employee Count

    n/a
    		 14

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 99.76% in the last 52 weeks. The beta is 2.24, so Sagimet Biosciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.24

    52-Week Price Change

    n/a
    		 99.76%

    50-Day Moving Average

    n/a
    		 3.5

    200-Day Moving Average

    n/a
    		 4.15

    Relative Strength Index (RSI)

    n/a
    		 84.21

    Average Volume (20 Days)

    n/a
    		 1,178,420

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -54.45M

    Net Income

    n/a
    		 -45.57M

    EBITDA

    n/a
    		 -45.57M

    EBIT

    n/a
    		 -45.57M

    Earnings Per Share (EPS)

    n/a
    		 -1.45
    Full Income Statement

    Balance Sheet

    The company has 75.84M in cash and 78K in debt, giving a net cash position of 75.76M.

    Cash & Cash Equivalents

    n/a
    		 75.84M

    Total Debt

    n/a
    		 78K

    Net Cash

    n/a
    		 75.76M

    Retained Earnings

    n/a
    		 -295.31M

    Total Assets

    n/a
    		 146.17M

    Working Capital

    n/a
    		 138.89M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -42.44M and capital expenditures 0, giving a free cash flow of -42.44M.

    Operating Cash Flow

    n/a
    		 -42.44M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -42.44M

    FCF Per Share

    n/a
    		 -1.35
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    SGMT does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for SGMT is $28.5, which is 244.6% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $28.5

    Price Target Difference

    n/a
    		 244.6%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 6
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 5.63

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist